Poland· PL-100079085
Sirupus Plantaginis Plantagen 12 cz Ekstraktu z Babki Lancetowatej
A medicinal product containing plantaginis lanceolatae folii extractum fluidum, registered in Poland by GEMIPHARMA Sp. z o.o..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Plantaginis lanceolatae folii extractum fluidum
- Manufacturer
- GEMIPHARMA Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990744329
- gtin05909990744312
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/974de2b1-9ab6-4d26-9606-84ca307c8f96 GET /v1/drugs/974de2b1-9ab6-4d26-9606-84ca307c8f96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Syrop",
"source": "urpl",
"strength": "1,5 g/10 ml",
"packaging": "05909990744329 ¦ OTC ¦ Skasowane ¦ 11737\n1 op. 150 g\n05909990744312 ¦ OTC ¦ 61325\n1 butelka 125 g",
"substance": "Plantaginis lanceolatae folii extractum (1:7) 12 g + Plantaginis lanceolatae extractum fluidum (1:2,0)",
"common_name": "Plantaginis lanceolatae folii extractum fluidum",
"pl_product_id": "100079085",
"pozwolenie_nr": "07443",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about plantaginis lanceolatae folii extractum fluidum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.